Alessio Vigani

Prof. Dr. Alessio Vigani

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2013 in Veterinary Quarterly
Verified
Journal Article
Open access
JEJessica A. Emerson
Jessica A. Emerson
JCJ. Brad Case
J. Brad Case
ABA. Paige Brock
A. Paige Brock
AVAlessio Vigani
Alessio Vigani
DGDanielle R. Graham
Danielle R. Graham
RIRamiro Isaza
Ramiro Isaza
Two tigers (Panthera tigris), six and seven years old, presented for laparoscopic ovariectomy. The tigers were privately owned and had never been bred. Both animals had been receiving 375 mg medrox...

4 March 2020 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Closed access
PDF file
MFMeghan E. Fick
Meghan E. Fick
KMKristen M. Messenger
Kristen M. Messenger
AVAlessio Vigani
Alessio Vigani

20 February 2020 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Closed access
PDF file
CCChristine A. Culler
Christine A. Culler
ARAlyx Reinhardt
Alyx Reinhardt
AVAlessio Vigani
Alessio Vigani

2 May 2022 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Open access
CCChristine A. Culler
Christine A. Culler
AVAlessio Vigani
Alessio Vigani
ARAlexandra Z. Ripoll
Alexandra Z. Ripoll
AGAlexandra Gareau
Alexandra Gareau
SSSteven E. Suter
Steven E. Suter
Objective: To describe the technique of centrifugal therapeutic plasma exchange (cTPE) in dogs diagnosed with immune‐mediated hemolytic anemia (IMHA) and summarize the outcome of the procedure.Design: Retrospective review of cTPE performed at North Carolina State University from 2016 to 2018, through a search of the institutional database for cTPE and IMHA.Setting: University teaching hospital.Animals: Seven dogs with confirmed IMHA were presented to a university teaching hospital ICU for cTPE. Six dogs were not responsive to standard medical management with immunosuppressive agents, while 1 dog presented before immunosuppressive agents were begun.Interventions: All dogs underwent multiple cTPE procedures using 1 of 2 commercially available apheresis systems.Measurements and Main Results: At presentation, the median HCT was 0.15 L/L (15.7%) (range, 0.10–0.19 L/L [10.3%–19%]) and the median total serum bilirubin was 32.5 mmol/L (1.9 mg/dl) (range, 15.4–597 mmol/L [0.9–34.9 mg/dl]). The median number of transfusions before cTPE was 1 (range, 1–4), with a median total of infused RBCs of 12.9 ml/kg (range, 8.8–37 ml/kg). cTPE with an exchange of ≥4 times total plasma volumes was used to decrease the level of circulating autoreactive antibodies. The median total plasma volumes exchanged was 4.5 times (range, 2.5–6.5 times) over 2–4 procedures. Anticoagulation was performed using a combination of systemic heparinization and regional citrate in all dogs. Six of 7 dogs (85.7%) were discharged from the hospital and were alive 90 days after discharge. One dog (14%) did not respond to cTPE (∼6.5 times total plasma volume exchanged) and was euthanized.Conclusions: cTPE is a feasible and relatively safe bridging treatment option for the management of canine IMHA.

23 September 2023 in Animals
Verified
Journal Article
Open access
PDF file
ARAna Rostaher
Ana Rostaher
NFNina Fischer
Nina Fischer
AVAlessio Vigani
Alessio Vigani
BSBarbara Steblaj
Barbara Steblaj
FMFranco Martini
Franco Martini
MKMitja Kosnik
Mitja Kosnik
Hymenoptera allergens are the main triggers for anaphylaxis in susceptible dogs and humans. Hymenoptera venom specific immunotherapy (VIT), the only disease-modifying treatment, has the potential to prevent future life-threatening reactions in human patients. Prospective clinical data on VIT efficacy in dogs are currently lacking. Therefore, the aim of this study was to show that VIT is not only safe but also efficacious in preventing anaphylaxis in dogs allergic to Hymenoptera. This uncontrolled prospective clinical trial included 10 client-owned dogs with a history of anaphylaxis following repeated Hymenoptera stings. The sensitization to bee and wasp allergens was demonstrated by intradermal testing (IDT) and allergen-specific IgE serology. For VIT induction (induction phase), dogs received a shortened rush immunotherapy protocol with aqueous allergens, which was then followed by monthly injections of 100 µg of alum-precipitated allergen (maintenance phase). VIT efficacy was determined by observing patients’ clinical reactions to re-stings. No systemic adverse events were seen during the induction and maintenance phases. From the seven re-stung dogs, only one developed a mild angioedema at the site of the sting; the remaining dogs were asymptomatic. These results show that VIT represents a safe and effective treatment option for Hymenoptera-allergic dogs.

14 December 2022 in Veterinary Medicine and Science
Verified
Journal Article
Open access
LGLinda Gabba
Linda Gabba
CIClaudia Iannucci
Claudia Iannucci
AVAlessio Vigani
Alessio Vigani
Objective: To describe the clinical efficacy and drug removal kinetics of hemodialysis (HD) as emergency treatment in a small size dog with severe baclofen intoxication.Case description: A 2‐year‐old dog was presented in stupor to the emergency service a few hours after ingestion of up to 25 mg of baclofen. Medical stabilisation was attempted but was unsuccessful in improving the neurological condition and the patient rapidly progressed to coma. A 4‐h session of HD was performed in emergency with near complete resolution of neurological signs and only mild disorientation by the end of the treatment. No adverse side effects occurred during HD. Baclofen concentration was measured serially during the session. Drug extraction ratio, clearance and mass removal by the dialyser were calculated. Dialytic elimination rate constant (Kd) was seven times higher than the intrinsic elimination rate constant (Kintr) and the half‐life (t½) during HD was nearly nine times shorter than the endogenous one.New or unique information provided: This is the first case report providing pharmacokinetic data associated with HD treatment of severe baclofen intoxication in a dog.